Risk assessment

vCJD BOTIA

Variant Creutzfeldt-Jakob disease risk assessment in a collection of blood samples from multi-transfused patients (the French BOTIA collection)

2015: 18 months / Grant: 100 000 euros

Project: For the projectvCJD BOTIA, highlysensitive PMCA-based assay was proposed to evaluate the prevalence of vCJD among multi-transfused patients that are considered to be a population risk (French BOTIA collection).

Main results and related published data: As this program has only been provided financial support recently, it is too early to present results.